Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection

References

• Malik R, Wigney DI, Martin P, Love DN, Muir DB. Veterinary aspects of cryptococcosis. Program and Abstracts, Second International Conference on Cryptococcus and Cryptococcosis 1993, Milan. Organizing Committee, Milan 1993; 29–29
   Google Scholar
• Malik R, Wigney DI, Muir DB, Gregory DJ, Love DN. Cryptococcosis in cats: clinical and mycological assessment of 29cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol 1992; 30: 133–144
   PubMedGoogle Scholar
• Malik R, Dill-Macky E, Martin P, Wigney DI, Muir DB, Love DN. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycol 1995; 33: 291–297
   PubMedGoogle Scholar
• Medleau L, Jacobs GJ, Marks MA. Itraconazole for the treatment of cryptococcosis in cats. J Vet Int Med 1995; 9: 39–42
   PubMed Web of Science ®Google Scholar
• Malik R, Craig AJ, Martin P, Wigney DI, Love DN. Combination chemotherapy of cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 1996; 73: 124–128
   PubMed Web of Science ®Google Scholar
• Diamond RD. Cryptococcus neoformans. Principles and Practice of Infectious Diseases3rd edn., GL Mandell, RG Douglas, JE Bennett. Churchill Livingstone, New York 1990; 1980–1999, In
   Google Scholar
• Dimech WJ. Diagnosis, identification and epidemiology of Cryptococcus neoformans infection. Aust J Med Lab Sci 1990; 12: 13–21
   Google Scholar
• Medleau L, Marks MA, Brown J, Borges WL. Clinical evaluation of a cryptococcal antigen latex agglutination test for diagnosis of cryptococcosis in cats. J Am Vet Med Assoc 1990; 196: 1470–1473
   PubMed Web of Science ®Google Scholar
• Malik R, McPetrie R, Wigney DI, Craig AJ, Love DN. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis. Aust Vet J 1996; 74: 358–364
   PubMed Web of Science ®Google Scholar
• Murphy JW. Cryptococcosis. Immunology of the Fungal Diseases, RA Cox. CRC Press Inc, Boca Raton, FL 1989; 94–138, In
   Google Scholar
• Dromer F, Aucouturier P, Clauvel J, Saimot S, Yen P. Cryptococcus neoformans antibody levels in patients with AIDS. Scand J Infect Dis 1988; 20: 283–285
   PubMed Web of Science ®Google Scholar
• Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 1987; 55: 749–752
   PubMed Web of Science ®Google Scholar
• Miller MF, Mitchell TG, Storkus WJ, Dawson JR. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun 1990; 58: 639–645
   PubMed Web of Science ®Google Scholar
• Zebedee, SL, Koduri, RK, Mukherjee, J, et al. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother 1994; 38: 1507–1514
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Lee SC, Casadevall A. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 1995; 63: 573–579
   PubMed Web of Science ®Google Scholar
• Mukherjee J, Zuckier LS, Scharff MD, Casadevall A. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother 1994; 38: 580–587
   PubMed Web of Science ®Google Scholar
• Speed BR, Kaldor J, Cairns B, Pegorer M. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects. J Med Vet Mycol 1996; 34: 187–193
   PubMedGoogle Scholar
• Gordon MA, Vedder DK. Serologic tests in diagnosis and prognosis of cryptococcosis. J Am Med Assoc 1966; 197: 131–137
   Web of Science ®Google Scholar
• Diamond RD, Bennet JE. Prognostic factors in cryptococcal meningitis. Ann Int Med 1974; 80: 176–181
   PubMed Web of Science ®Google Scholar
• Henderson DK, Bennett JE, Huber MA. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J Clin Invest 1982; 69: 1185–1190
   PubMed Web of Science ®Google Scholar
• Scott NE, Felton FG, Muchmore HG. Development of an enzyme immunoassay for cryptococcal antibody. Mycopathologica 1980; 70: 55–59
   PubMed Web of Science ®Google Scholar
• Houpt DC, Pfrommer GS, Young BJ, Larson TA, Kozel TR. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect Immun 1994; 62: 2857–2864
   PubMed Web of Science ®Google Scholar
• Speed BR, Cairns B, Kaldor J (1993) The seroepidemiology of Cryptococcus neoformans utilising class-specific antibodies detected by enzyme immunoassay. Program and Abstracts, Second International Conference on Cryptococcus and Cryptococcosis, Milan, 1993. Organizing Committee, Milan, 2–6, [Abstract]
   Google Scholar
• Flatman B, Greene RT, Lappin MR. Clinical and serological evaluation of cats with cryptococcosis. J Am Vet Med Assoc 1996; 209: 1110–1113
   PubMed Web of Science ®Google Scholar
• Gray LD, Roberts GD. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol 1988; 26: 2451–2452
   Web of Science ®Google Scholar
• Malik R, Kendall K, Cridland J, Coulston S, Stuart AJ, Snow D, Love DN. Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust Vet J 1997; 75: 323–327
   PubMed Web of Science ®Google Scholar
• Malik R, Wigney DI, Muir D, Love DN. Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of dogs and cats. J Med Vet Mycol 1997; 35: 27–31
   PubMedGoogle Scholar
• Malik, R, Martin, P, Wigney, DI, Church, DB, et al. Nasopharyngeal cryptococcosis. Aust Vet J 1997; 75: 483–488
   PubMed Web of Science ®Google Scholar
• Walker C, Malik R, Canfield PJ. Analysis of leucocytes and lymphocyte subsets in cats with naturally occurring cryptococcosis but differing feline immunodeficiency virus status. Aust Vet J 1995; 72: 93–96
   PubMed Web of Science ®Google Scholar
• Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13: 1163–1169
   PubMedGoogle Scholar
• Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642–1644
   PubMed Web of Science ®Google Scholar
• Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottleib T. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611–616
   PubMed Web of Science ®Google Scholar
• Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28–34
   PubMed Web of Science ®Google Scholar